| DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE | None | ||
| 2.5MG;1000MG;2.5MG, 5MG;1000MG;2.5MG, 5MG;1000MG;5MG, 10MG;1000MG;5MG |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| QTERNMET XR is a sodium-glucose cotransporter 2 (SGLT2) inhibitor, a dipeptidyl peptidase-4 (DPP-4) inhibitor and a biguanide combination product indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. | |||
|
Yes
| |||
| QTERNMET XR | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | |||||||||||||||
| *-**** ********* ***** ********** *** ****** | ******* ********** ** ***** ********** *** ********* *** ********* **** | ******* ********** ** ***** ********** *** ********* *** ********* **** | ******* ********** ** ***** ********** *** ********* *** ********* **** | ******* ********** ** ***** ********** *** ********* *** ********* **** | ************** ************ ********** ** ***** ********* | ************** ************ ********** ** ***** ********* | ******* ****** ************ | ******* ****** ************ | *-**** ********* ***** ********** *** ****** | *-**** ********* ***** ********** *** ****** | ************** ************ ********** ** ***** ********* | ***********-***** ***********-***** ********** ** ********** ********* ** *** ****** | ****** ****** *********** *** ****** | *-**** ********* ***** ********** *** ****** |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|